Targeting CD20+ Rituxan resistant B-cells with anti-CD3 activated T cells (ATC) armed with anti-CD3 x anti-CD20 (CD20Bi)

被引:0
|
作者
Gall, JM
Grabert, RC
Deavers, M
Davoll, PA
Lum, LG
机构
[1] Roger Williams Med Ctr, Providence, RI USA
[2] Boston Univ, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
19
引用
收藏
页码:35 / 35
页数:1
相关论文
共 50 条
  • [41] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04) : A59 - A59
  • [42] Anti-CD20 for rheumatoid arthritis
    Edwards, JC
    Leandro, MJ
    Cambridge, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 25
  • [43] Immunotherapy with anti-CD20 compounds
    von Schilling, C
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 211 - 222
  • [44] Effects of ultrasound on apoptosis induced by anti-CD20 antibody in CD20-positive B lymphoma cells
    Danno, Daisuke
    Kanno, Masatoshi
    Fujimoto, Shinichi
    Feril, Loreto B., Jr.
    Kondo, Takashi
    Nakamura, Shinobu
    ULTRASONICS SONOCHEMISTRY, 2008, 15 (04) : 463 - 471
  • [45] CD3+ CD20+ T cells and their roles in human diseases
    Chen, Qin
    Yuan, Shunling
    Sun, Hongwu
    Peng, Liusheng
    HUMAN IMMUNOLOGY, 2019, 80 (03) : 191 - 194
  • [46] Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion
    Buhmann, R.
    Simoes, B.
    Stanglmaier, M.
    Yang, T.
    Faltin, M.
    Bund, D.
    Lindhofer, H.
    Kolb, H-J
    BONE MARROW TRANSPLANTATION, 2009, 43 (05) : 383 - 397
  • [47] Anti-CD20 in hematologic oncology
    Milpied, Noel
    PRESSE MEDICALE, 2009, 38 (05): : 788 - 798
  • [48] Anti-CD20 diabodies for targeting and imaging lymphoma
    Olafsen, Tove
    Sirk, Shannon
    Betting, David
    Kenanova, Vania
    Raubitschek, Andrew
    Timmerman, John
    Wu, Anna
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [49] Activated T Cells (ATC) Armed with Anti-CD3 X Anti-Her2/Neu Bispecific Antibody (Her2Bi) Is a Potent Immunomodulator.
    Norkina, Oxana
    Thakur, Archana
    Norkin, Maxim
    Paul, Elyse
    Al-Kadhimi, Zaid
    Lum, Lawrence G.
    BLOOD, 2008, 112 (11) : 888 - 888
  • [50] A novel immunoregulatory role for anti-CD3 mAbs: Dendritic cells, pulsed with tumor cells and armed with anti-CD3 mAbs, are highly effective in constraining tumor progression.
    Maluccio, M
    Rao, J
    Sharma, VK
    Lagman, M
    Suthanthiran, M
    TRANSPLANTATION, 1999, 67 (07) : S210 - S210